Related Experiment Video
Updated: Mar 24, 2026

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
The Genetics-Driven Revival in Neuropsychiatric Drug Development
Michael J Gandal1, Daniel H Geschwind2
1Program in Neurobehavioral Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Center for Autism Research and Treatment, and Department of Psychiatry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Semel Institute, and Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Drug Discovery: Overview
Drugs Affecting Neurotransmitter Synthesis
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetics and Pharmacogenomics: Overview
Psychosis: Goals of Pharmacotherapy

